fbpixel

Our website uses cookies to help enhance your browsing experience. Continue to browse our site if you agree to our use of cookies as described in Unilab's Cookie Policy .

For information on how we protect your privacy, please read our Privacy Policy .

alfaren
Formulation
Each film-coated tablet contains:
Calcium-4-methyl-2-oxo-valerate (α-ketoanalogue to leucine, calcium salt) 101 mg
Calcium-2-oxo-3-phenylpropionate (α-ketoanalogue to phenylalanine, calcium salt) 68 mg
Calcium-3-methyl-2-oxo-valerate (α-ketoanalogue to isoleucine, calcium salt) 67 mg
Calcium-DL-2-hydroxy-4-(methylthio)butyrate (α-hydroxyanalogue to methionine, calcium salt)  59 mg
L-Lysine Acetate 105 mg
L-Threonine 53 mg
L-Histidine 38 mg
L-Tyrosine 30 mg
L-Tryptophan 23 mg

Ketoanalogues +
Essential Amino Acids

Alfaren®

Prescription Drug

Indication

Prevention and treatment of damages due to faulty or deficient protein metabolism in chronic kidney disease in connection with a limited dietary protein intake of 40g/day or less (adults). Usually this applies to patients whose glomerular filtration rate (GFR) is less than 25mL/min.

Dosage and Administration:

For more information on safety, precaution and other information about this product, please see the Product Information Leaflet